Association of Hemodynamic Variables with the Risk of Heart transplant Waitlist Death and Deterioration
Journal of Cardiac Failure · 2025
DOI: 10.1016/j.cardfail.2025.09.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiac Failure, 2025. Verfasst von Aaron M Wolfson und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Keck School of Medicine of the University of Southern California, Los Angeles, California; Department of Medicin…. Hauptthemen laut MEDLINE: Waiting Lists, Heart Transplantation, Hemodynamics, Heart Failure. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
The 2018 United Network for Organ Sharing heart allocation policy relies on discrete hemodynamic cutoffs for status stratification, evaluating systolic blood pressure, pulmonary capillary wedge pressure, and cardiac index. Although the policy change has generally resulted in improved overall waitlist outcomes, worsening post-transplant survival in certain groups and increased exception requests raise concern regarding its efficacy. We analyzed 2393 adult status 1-3 patients not on mechanical circulatory support at the time of hemodynamic assessment. We used cause-specific Cox models with restricted cubic splines to evaluate the association between an expanded panel of hemodynamic variables and waitlist death or deterioration. Cardiac power output of the left ventricle and the pulmonary artery pulsatility index displayed nonlinear associations with waitlist death or deterioration. In contrast, central venous pressure, mean pulmonary artery pressure, effective arterial elastance of the pulmonary artery, and left ventricular stroke work index showed linear associations with waitlist death or deterioration, whereas systolic blood pressure and pulmonary capillary wedge pressure trended toward linear associations. Cardiac index was not associated with the risk of waitlist death or deterioration. Our findings highlight possible areas for improvement in the risk stratification of heart transplant candidates and the use of advanced hemodynamic variables in future allocation policy iterations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiovascular Medicine, Keck School of Medicine of the University of Southern California, Los Angeles, California; Department of Medicine, Keck School of Medicine of the University of Southern California, L…
- Keck School of Medicine, University of Southern California, Los Angeles, California.
- Department of Medicine, Keck School of Medicine of the University of Southern California, Los Angeles, California.
- Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, California.
- Department of Cardiothoracic Surgery, Keck School of Medicine of the University of Southern California, Los Angeles, California; USC Cardiac and Vascular Institute, Los Angeles, California.
Zitieren
APA
Wolfson, A. M., Ferrall, J., Lam, V., Hage, P., Chen, M. S., Nattiv, J., Pandya, K., Stachel, M., Kawakguchi, E. S., Lee, R., & Vaidya, A. S. (2025). Association of Hemodynamic Variables with the Risk of Heart transplant Waitlist Death and Deterioration. Journal of Cardiac Failure. https://doi.org/10.1016/j.cardfail.2025.09.003
Vancouver
Wolfson AM, Ferrall J, Lam V, Hage P, Chen MS, Nattiv J, et al. Association of Hemodynamic Variables with the Risk of Heart transplant Waitlist Death and Deterioration. Journal of Cardiac Failure. 2025. doi:10.1016/j.cardfail.2025.09.003
BibTeX
@article{Wolfson2025,
author = {Wolfson, Aaron M and Ferrall, Joel and Lam, Vincent and Hage, Paul and Chen, Matthew S and Nattiv, Jonathan and Pandya, Kruti and Stachel, Maxine and Kawakguchi, Eric S and Lee, Raymond and Vaidya, Ajay S},
title = {Association of Hemodynamic Variables with the Risk of Heart transplant Waitlist Death and Deterioration},
journal = {Journal of Cardiac Failure},
year = {2025},
doi = {10.1016/j.cardfail.2025.09.003}
}
EUVIMED